Medexus Pharmaceuticals Inc. (MEDXF)
OTCMKTS · Delayed Price · Currency is USD
2.150
+0.070 (3.37%)
Jan 8, 2026, 3:45 PM EST
Medexus Pharmaceuticals Market Cap
Medexus Pharmaceuticals has a market cap or net worth of $67.83 million as of January 8, 2026. Its market cap has increased by 51.61% in one year.
Market Cap
67.83M
Enterprise Value
79.61M
Revenue
104.10M
Ranking
n/a
PE Ratio
178.04
Stock Price
$2.15
Market Cap Chart
Since December 27, 2013, Medexus Pharmaceuticals's market cap has increased from 30.10M to 67.83M, an increase of 125.33%. That is a compound annual growth rate of 6.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 67.83M | -1.50% |
| Dec 31, 2025 | 68.86M | 15.93% |
| Dec 31, 2024 | 59.40M | 29.86% |
| Dec 29, 2023 | 45.74M | 48.80% |
| Dec 30, 2022 | 30.74M | -23.08% |
| Dec 31, 2021 | 39.97M | -48.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 824.30M |
| Glass House Brands | 714.29M |
| Elite Pharmaceuticals | 516.25M |
| Northwest Biotherapeutics | 444.91M |
| Nika Pharmaceuticals | 395.17M |
| American Oncology Network | 394.40M |
| CytoDyn | 368.24M |
| Silence Therapeutics | 270.65M |